Skin and Soft Tissue Infections

Surgical Clinics of North America

Volumn 89, Issue 2, 2009, Pages 403-420

  May, Addison K ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Necrotizing fasciitis; Necrotizing soft tissue infection; Skin and skin structure infection; Skin and soft tissue infection

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFTAROLINE; CEFTOBIPROLE; CEFTRIAXONE; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; COTRIMOXAZOLE; DALBAVANCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERTAPENEM; ERYTHROMYCIN; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MEROPENEM; METICILLIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; TELAVANCIN; TETRACYCLINE; TIGECYCLINE; TIMENTIN; UNINDEXED DRUG; VANCOMYCIN;

ABSCESS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL VIRULENCE; BETA HEMOLYTIC STREPTOCOCCUS; BURN INFECTION; CELLULITIS; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEBRIDEMENT; DIABETES MELLITUS; DISABILITY; DRUG EFFICACY; ENTEROBACTER; ENTEROCOCCUS; ERYSIPELAS; ESCHERICHIA COLI; FOLLICULITIS; FURUNCULOSIS; HOSPITALIZATION; HUMAN; INFECTION COMPLICATION; INFECTION RISK; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NECROTIZING FASCIITIS; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RESUSCITATION; REVIEW; SERRATIA; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; SURGEON; SURGICAL DRAINAGE; TOXIC SHOCK SYNDROME; ULCER; VANCOMYCIN RESISTANT ENTEROCOCCUS; WOUND INFECTION;

ANTI-INFECTIVE AGENTS; COMBINED MODALITY THERAPY; DEBRIDEMENT; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NECROSIS; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS;

EID: 61549085952     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2008.09.006     Document Type: Review

References (99)

1. Guidance for Industry: Uncomplicated and complicated skin and skin structure infections: developing antimicrobial drugs treatment. US Dept of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 1998. Available at: http://www.fda.gov/CDER/guidance/2566dft.pdf. Accessed October 17, 2008.
2. Jones M.E., Karlowsky J.A., Draghi D.C., et al. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int J Antimicrob Agents 22 (2003) 406-419
3. Stevens D.L., Bisno A.L., Chambers H.F., et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41 (2005) 1373-1406
4. Elliott D.C., Kufera J.A., and Myers R.A. Necrotizing soft tissue infections: risk factors for mortality and strategies for management. Ann Surg 224 (1996) 672-683
5. Moet G.J., Jones R.N., Biedenbach D.J., et al. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY antimicrobial surveillance program (1998-2004). Diagn Microbiol Infect Dis 57 (2007) 7-13
6. Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 40 (2005) 562-573
7. Fridkin S.K., Hageman J.C., Morrison M., et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352 (2005) 1436-1444
8. King M.D., Humphrey B.J., Wang Y.F., et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 144 (2006) 309-317
9. Moran G.J., Amii R.N., Abrahamian F.M., et al. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 11 (2005) 928-930
10. Doern G.V., Jones R.N., Pfaller M.A., et al. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the sentry antimicrobial surveillance program (United States and Canada, 1997). Sentry Study Group (North America). Diagn Microbiol Infect Dis 34 (1999) 65-72
11. Naimi T.S., LeDell K.H., Como-Sabetti K., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290 (2003) 2976-2984
12. Miller L.G., Perdreau-Remington F., Rieg G., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352 (2005) 1445-1453
13. Llera J.L., and Levy R.C. Treatment of cutaneous abscess: a double-blind clinical study. Ann Emerg Med 14 (1985) 15-19
14. Swartz M.N. Clinical practice. Cellulitis. N Engl J Med 350 (2004) 904-912
15. Hsiao C.T., Weng H.H., Yuan Y.D., et al. Predictors of mortality in patients with necrotizing fasciitis. Am J Ethics Med 26 (2008) 170-175
16. Wong C.H., Chang H.C., Pasupathy S., et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 85-A (2003) 1454-1460
17. Wong C.H., Khin L.W., Heng K.S., et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 32 (2004) 1535-1541
18. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA 269 (1993) 390-391
19. Dupuy A., Benchikhi H., Roujeau J.C., et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 318 (1999) 1591-1594
20. Mascini E.M., Jansze M., Schouls L.M., et al. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int J Antimicrob Agents 18 (2001) 395-398
21. Zimbelman J., Palmer A., and Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 18 (1999) 1096-1100
22. Stevens D.L., Gibbons A.E., Bergstrom R., et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 158 (1988) 23-28
23. Bernard P., Plantin P., Roger H., et al. Roxithromycin versus penicillin in the treatment of erysipelas in adults: a comparative study. Br J Dermatol 127 (1992) 155-159
24. Bosshardt T.L., Henderson V.J., and Organ Jr. C.H. Necrotizing soft-tissue infections. Arch Surg 131 (1996) 846-852
25. Brook I., and Frazier E.H. Aerobic and anaerobic bacteriology of wounds and cutaneous abscesses. Arch Surg 125 (1990) 1445-1451
26. Green R.J., Dafoe D.C., and Raffin T.A. Necrotizing fasciitis. Chest 110 (1996) 219-229
27. Stevens D.L., Herr D., Lampiris H., et al. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 34 (2002) 1481-1490
28. Weigelt J., Itani K., Stevens D., et al. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrobial Agents Chemother 49 (2005) 2260-2266
29. Stevens D.L., Wallace R.J., Hamilton S.M., et al. Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics. Clin Infect Dis 42 (2006) 729-730
30. Ellis-Grosse E.J., Babinchak T., Dartois N., et al. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam. Clin Infect Dis 5 41 Suppl (2005) S341-S353
31. Raghavan M., and Linden P.K. Newer treatment options for skin and soft tissue infections. Drugs 64 (2004) 1621-1642
32. Adant J.P., Bluth F., and Fissette J. Necrotizing fasciitis: a life-threatening infection. Acta Chir Belg 98 (1998) 102-106
33. Adinolfi M.F., Voros D.C., Moustoukas N.M., et al. Severe systemic sepsis resulting from neglected perineal infections. South Med J 76 (1983) 746-749
34. Anaya D.A., McMahon K., Nathens A.B., et al. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 140 (2005) 151-157
35. Asfar S.K., Baraka A., Juma T., et al. Necrotizing fasciitis. Br J Surg 78 (1991) 838-840
36. Bakleh M., Wold L.E., Mandrekar J.N., et al. Correlation of histopathologic findings with clinical outcome in necrotizing fasciitis. Clin Infect Dis 40 (2005) 410-414
37. Barzilai A., Zaaroor M., and Toledano C. Necrotizing fasciitis: early awareness and principles of treatment. Isr J Med Sci 21 (1985) 127-132
38. Bilton B.D., Zibari G.B., McMillan R.W., et al. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg 64 (1998) 397-400
39. Brandt M.M., Corpron C.A., and Wahl W.L. Necrotizing soft tissue infections: a surgical disease. Am Surg 66 (2000) 967-970
40. Brown D.R., Davis N.L., Lepawsky M., et al. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg 167 (1994) 485-489
41. Casali R.E., Tucker W.E., Petrino R.A., et al. Postoperative necrotizing fasciitis of the abdominal wall. Am J Surg 140 (1980) 787-790
42. Catena F., La Donna M., Ansaloni L., et al. Necrotizing fasciitis: a dramatic surgical emergency. Eur J Emerg Med 11 (2004) 44-48
43. Cheng N.C., Tai H.C., Tang Y.B., et al. Necrotising fasciitis: clinical features in patients with liver cirrhosis. Br J Plast Surg 58 (2005) 702-707
44. Childers B.J., Potyondy L.D., Nachreiner R., et al. Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am Surg 68 (2002) 109-116
45. Chow L.W.C., Ong C., Damien J.C.P., et al. Necrotizing fasciitis revisited. Contemp Surg 42 (1993) 181-184
46. Clayton M.D., Fowler Jr. J.E., Sharifi R., et al. Causes, presentation and survival of fifty-seven patients with necrotizing fasciitis of the male genitalia. Surg Gynecol Obstet 170 (1990) 49-55
47. Endorf F.W., Supple K.G., and Gamelli R.L. The evolving characteristics and care of necrotizing soft-tissue infections. Burns 31 (2005) 269-273
48. 2) for treatment of necrotizing fasciitis reduces mortality and amputation rate. Undersea Hyperb Med 32 (2005) 437-443
49. Francis K.R., Lamaute H.R., Davis J.M., et al. Implications of risk factors in necrotizing fasciitis. Am Surg 59 (1993) 304-308
50. Frazee B.W., Fee C., Lynn J., et al. Community-acquired necrotizing soft tissue infections: a review of 122 cases presenting to a single emergency department over 12 years. J Emerg Med 34 (2008) 139-146
51. Freeman H.P., Oluwole S.F., Ganepola G.A., et al. Necrotizing fasciitis. Am J Surg 142 (1981) 377-383
52. Freischlag J.A., Ajalat G., and Busuttil R.W. Treatment of necrotizing soft tissue infections. the need for a new approach. Am J Surg 149 (1985) 751-755
53. Fustes-Morales A., Gutierrez-Castrellon P., Duran-Mckinster C., et al. Necrotizing fasciitis: report of 39 pediatric cases. Arch Dermatol 138 (2002) 893-899
54. Gallup D.G., Freedman M.A., Meguiar R.V., et al. Necrotizing fasciitis in gynecologic and obstetric patients: a surgical emergency. Am J Obstet Gynecol 187 (2002) 305-310
55. Golger A., Ching S., Goldsmith C.H., et al. Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg 119 (2007) 1803-1807
56. Gozal D., Ziser A., Shupak A., et al. Necrotizing fasciitis. Arch Surg 121 (1986) 233-235
57. Gunter OL, Guillamondegui OD, May AK, et al. Improved outcome in necrotizing fasciitis; an Emergency General Surgery Service Experience. Presented at the 27th Annual Meeting of the Surgical Infection Society, Toronto. 2007.
58. Haywood C.T., McGeer A., and Low D.E. Clinical experience with 20 cases of group A streptococcus necrotizing fasciitis and myonecrosis: 1995 to 1997. Plast Reconstr Surg 103 (1999) 1567-1573
59. Hefny A.F., Eid H.O., Al Hussona M., et al. Necrotizing fasciitis: a challenging diagnosis. Eur J Emerg Med 14 (2007) 50-52
60. Hsiao G.H., Chang C.H., Hsiao C.W., et al. Necrotizing soft tissue infections: surgical or conservative treatment?. Dermatol Surg 24 (1998) 243-247
61. Kaiser R.E., and Cerra F.B. Progressive necrotizing surgical infections: a unified approach. J Trauma 21 (1981) 349-355
62. Kao L.S., Knight M.T., Lally K.P., et al. The impact of diabetes in patients with necrotizing soft tissue infections. Surg Infect (Larchmt) 6 (2005) 427-438
63. Kwan M.K., Saw A., Chee E.K., et al. Necrotizing fasciitis of the lower limb: an outcome study of surgical treatment. Med J Malaysia 61 Suppl A (2006) 17-20
64. Lee T.C., Carrick M.M., Scott B.G., et al. Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital. Am J Surg 194 (2007) 809-812
65. Legbo J.N., and Shehu B.B. Necrotizing fasciitis: a comparative analysis of 56 cases. J Natl Med Assoc 97 (2005) 1692-1697
66. Liu B.M., Chung K.J., Chen C.H., et al. Risk factors for the outcome of cirrhotic patients with soft tissue infections. J Clin Gastroenterol 42 (2008) 312-316
67. Liu Y.M., Chi C.Y., Ho M.W., et al. Microbiology and factors affecting mortality in necrotizing fasciitis. J Microbiol Immunol Infect 38 (2005) 430-435
68. Majeski J.A., and Alexander J.W. Early diagnosis, nutritional support, and immediate extensive debridement improve survival in necrotizing fasciitis. Am J Surg 145 (1983) 784-787
69. McHenry C.R., Piotrowski J.J., Petrinic D., et al. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 221 (1995) 558-563
70. Miller A.T., Saadai P., Greenstein A., et al. Postprocedural necrotizing fasciitis: a 10-year retrospective review. Am Surg 74 (2008) 405-409
71. Miller J.D. The importance of early diagnosis and surgical treatment of necrotizing fasciitis. Surg Gynecol Obstet 157 (1983) 197-200
72. Ogilvie C.M., and Miclau T. Necrotizing soft tissue infections of the extremities and back. Clin Orthop Relat Res 447 (2006) 179-186
73. Oh C., Lee C., and Jacobson J.H. Necrotizing fasciitis of perineum. Surgery 91 (1982) 49-51
74. Ozalay M., Ozkoc G., Akpinar S., et al. Necrotizing soft-tissue infection of a limb: clinical presentation and factors related to mortality. Foot Ankle Int 27 (2006) 598-605
75. Peer S.M., Rodrigues G., Kumar S., et al. A clinicopathological study of necrotizing fasciitis: an institutional experience. J Coll Physicians Surg Pak 17 (2007) 257-260
76. Pessa M.E., and Howard R.J. Necrotizing fasciitis. Surg Gynecol Obstet 161 (1985) 357-361
77. Qazi S.A., Mohammed A.A., Saber E.I., et al. Necrotizing fasciitis: role of early surgical intervention. Saudi Med J 25 (2004) 890-894
78. Rouse T.M., Malangoni M.A., and Schulte W.J. Necrotizing fasciitis: a preventable disaster. Surgery 92 (1982) 765-770
79. Singh G., Sinha S.K., Adhikary S., et al. Necrotising infections of soft tissues: a clinical profile. Eur J Surg 168 (2002) 366-371
80. Spirnak J.P., Resnick M.I., Hampel N., et al. Fournier's gangrene: report of 20 patients. J Urol 131 (1984) 289-291
81. Stamenkovic I., and Lew P.D. Early recognition of potentially fatal necrotizing fasciitis: the use of frozen-section biopsy. N Engl J Med 310 (1984) 1689-1693
82. Sudarsky L.A., Laschinger J.C., Coppa G.F., et al. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg 206 (1987) 661-665
83. Taviloglu K., Cabioglu N., Cagatay A., et al. Idiopathic necrotizing fasciitis: risk factors and strategies for management. Am Surg 71 (2005) 315-320
84. Theis J.C., Rietveld J.,. Danesh-Clough T. Severe necrotising soft tissue infections in orthopaedic surgery. J Orthop Surg (Hong Kong) 10 (2002) 108-113
85. Tillou A., St Hill C.R., Brown C., et al. Necrotizing soft tissue infections: improved outcomes with modern care. Am Surg 70 (2004) 841-844
86. Tiu A., Martin R., Vanniasingham P., et al. Necrotizing fasciitis: analysis of 48 cases in South Auckland, New Zealand. ANZ J Surg 75 (2005) 32-34
87. Tsai Y.H., Hsu R.W., Huang T.J., et al. Necrotizing soft-tissue infections and sepsis caused by Vibrio vulnificus compared with those caused by Aeromonas species. J Bone Joint Surg Am 89 (2007) 631-636
88. Walker M., and Hall Jr. M. Necrotizing fasciitis: the Howard University Hospital experience. J Natl Med Assoc 75 (1983) 159-163
89. Wall D.B., de Virgilio C., Black S., et al. Objective criteria may assist in distinguishing necrotizing fasciitis from nonnecrotizing soft tissue infection. Am J Surg 179 (2000) 17-21
90. Wang K.C., and Shih C.H. Necrotizing fasciitis of the extremities. J Trauma 32 (1992) 179-182
91. Ward R.G., and Walsh M.S. Necrotizing fasciitis: 10 years' experience in a district general hospital. Br J Surg 78 (1991) 488-489
92. Wilkinson D., and Doolette D. Hyperbaric oxygen treatment and survival from necrotizing soft tissue infection. Arch Surg 139 (2004) 1339-1345
93. Yaghoubian A., de Virgilio C., Dauphine C., et al. Use of admission serum lactate and sodium levels to predict mortality in necrotizing soft-tissue infections. Arch Surg 142 (2007) 840-846
94. Yilmazlar T., Ozturk E., Alsoy A., et al. Necrotizing soft tissue infections: APACHE II score, dissemination, and survival. World J Surg 31 (2007) 1858-1862
95. Vinh D.C., and Embil J.M. Rapidly progressive soft tissue infections. Lancet Infect Dis 5 (2005) 501-513
96. Nichols R.L., and Florman S. Clinical presentations of soft-tissue infections and surgical site infections. Clin Infect Dis 33 Suppl 2 (2001) S84-S93
97. Eke N. Fournier's gangrene: a review of 1726 cases. Br J Surg 87 (2000) 718-728
98. Echols J., Friedman B., Mullins R., et al. Initial experience with a new system for the control and containment of fecal output for the protection of patients in a large burn center. Chest 126 (2004) 862S
99. Anaya D.A., and Dellinger E.P. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 44 (2007) 705-710